L3, also known as 1,19-Bis(2-hexyldecyl)10- [[3-(dimethylamino)propyl](1-oxooctyl)amino]nonadecanedioate, is a derivative of MC3 that can be exploited for creating lipid nanoparticles (LNPs).
L13, also known as 1-Octylnonyl 8-[(2-hydroxyethyl)[4-(nony loxy)-4-oxobutyl]amino]octanoate, may be applied in the generation of lipid nanoparticles (LNPs).
L14, also known as 1-Octylnonyl 8-[(2-hydroxyethyl)[8-[(1-methylnonyl)oxy]-8-oxooctyl]amino]octanoate, is an SM-102 analog used in the formation of lipid nanoparticles (LNPs).
L15, also known as 1-Octylnonyl 8-[[3-[[2-(methylamino)-3,4-dioxo-1-cyclobuten-1-yl]amino] propyl] [8- (nonyloxy)-8-oxooctyl] amino]octanoate, may be employed in the development of lipid nanoparticles (LNPs).
L16, also known as ((3-((2-(methylamino)-3,4-dioxocyclobut-1-en-1-yl)amino)propyl)azanediyl)bis (hexane- 6,1-diyl) bis(2-hexyldecanoate), serves as a component for lipid nanoparticles (LNPs).
